Hsing C Pao, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pao’s office at (408) 871-3400 to ask if they take your plan before you enroll.
California Medical Board record
Licence A145634 · Current
Licensed to practise in California · since 2016 · expires 2027-12-31 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125065903Temporary Medical Permit · since 2014 · expires 2017-06-30Specialty on the licence: Family MedicineExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$47,026
Medicare paid this office $47,026 for 137 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 43 | $9,784 | $160 |
| Return visit (30+ min) | 37 | $6,707 | $106 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 22 | $6,334 | $288 |
| Short return visit (20+ min) | 56 | $5,567 | $76 |
| New patient visit (45+ min) | 23 | $2,574 | $112 |
See all 12 services
| Long return visit (40+ min) | 43 | $9,784 | $160 |
| Return visit (30+ min) | 37 | $6,707 | $106 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 22 | $6,334 | $288 |
| Short return visit (20+ min) | 56 | $5,567 | $76 |
| New patient visit (45+ min) | 23 | $2,574 | $112 |
| New patient visit (60+ min) | 18 | $2,539 | $141 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,361 | $157 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 91 | $2,226 | $14 |
| New patient visit (30+ min) | 14 | $1,266 | $90 |
| Influenza vaccine split virus, preservative free | 15 | $1,208 | $81 |
| Administration of pneumococcal vaccine | 22 | $860 | $39 |
| Administration of influenza virus vaccine | 17 | $664 | $39 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
137 Original Medicare patients in 2024. Average age 75 · Women 39% · Also on Medicaid 11% · Health risk score 1.03. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 62% · Diabetes 31% · Coronary heart disease 20% · Cancer 17% · Atrial fibrillation 17% · Chronic kidney disease 16% · Heart failure 14% · COPD 12% · Stroke 12% · Depression 9% · Dementia 9%.
The office billed $185,478, Medicare allowed $62,082 and paid $47,026; for 567 services of 33 kinds; $8,175 of it was for drugs given in the office and $38,850 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 137 | 567 | 75 | 1.03 | $185,478 | $47,026 |
| 2023 | 37 | 88 | 76 | 1.00 | $30,854 | $8,431 |
| 2020 | 15 | 22 | 76 | 0.81 | $3,810 | $1,561 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 14 | $1,681 | $105 |
| Short return visit (20+ min) | 11 | $1,225 | $88 |
Drugs they prescribed that Part D paid
$64,435
Pharmacies billed $64,435 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (12 of 786) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
701 generic and fewer than 11 brand-name prescriptions · $64,435 in drug cost · 14 antibiotic prescriptions to 11 people · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $9,147 | $832 |
| Atorvastatin | 95 | $461 | $5 |
| Gabapentin | 23 | $372 | $16 |
| Rosuvastatin | 17 | $322 | $19 |
| Metoprolol | 28 | $314 | $11 |
See all 21 drugs
| Eliquis | 11 | $9,147 | $832 |
| Atorvastatin | 95 | $461 | $5 |
| Gabapentin | 23 | $372 | $16 |
| Rosuvastatin | 17 | $322 | $19 |
| Metoprolol | 28 | $314 | $11 |
| Lisinopril | 29 | $258 | $9 |
| Losartan | 30 | $243 | $8 |
| Tamsulosin | 26 | $238 | $9 |
| Omeprazole | 17 | $213 | $13 |
| Amlodipine Besylate | 46 | $153 | $3 |
| Nifedipine Er | 12 | $145 | $12 |
| Metformin | 16 | $102 | $6 |
| Metformin Hcl Er | 15 | $95 | $6 |
| Pantoprazole | 14 | $88 | $6 |
| Ezetimibe | 11 | $83 | $8 |
| Finasteride | 14 | $78 | $6 |
| Levothyroxine | 20 | $67 | $3 |
| Quetiapine | 11 | $66 | $6 |
| Alendronate | 12 | $56 | $5 |
| Metoprolol | 11 | $55 | $5 |
| Carvedilol | 14 | $55 | $4 |
Year by year
| 2024 | 786 | 162 | 2% (12) | None | $64,435 |
| 2023 | 43 | 25 | 0% (0) | None | $1,093 |
| 2022 | 98 | 40 | 0% (0) | None | $2,604 |
| 2021 | 721 | 114 | 2% (14) | None | $46,559 |
| 2020 | 602 | 151 | None | 9% | $20,821 |
| 2019 | 1,283 | 271 | 7% (94) | None | $44,273 |
| 2018 | 915 | 210 | 8% (76) | None | $35,333 |
| 2017 | 299 | 96 | 5% (16) | None | $8,251 |
| 2016 | 115 | 27 | 0% (0) | None | $11,838 |
| 2015 | 12 | None | 0% (0) | None | $473 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 17 drugs
| Eliquis | 11 | $5,273 | $479 |
| Atorvastatin | 65 | $805 | $12 |
| Levothyroxine | 24 | $779 | $32 |
| Metoprolol | 25 | $605 | $24 |
| Losartan | 29 | $441 | $15 |
| Allopurinol | 12 | $392 | $33 |
| Omeprazole | 12 | $380 | $32 |
| Famotidine | 11 | $277 | $25 |
| Gabapentin | 21 | $271 | $13 |
| Amlodipine Besylate | 33 | $260 | $8 |
| Tamsulosin | 21 | $242 | $12 |
| Metformin Hcl Er | 27 | $240 | $9 |
| Rosuvastatin | 19 | $235 | $12 |
| Lisinopril | 39 | $170 | $4 |
| Hydrochlorothiazide | 22 | $155 | $7 |
| Metformin | 17 | $113 | $7 |
| Simvastatin | 14 | $103 | $7 |
2020: 14 drugs
| Atorvastatin | 69 | $1,088 | $16 |
| Levothyroxine | 25 | $781 | $31 |
| Metoprolol | 13 | $407 | $31 |
| Losartan | 33 | $398 | $12 |
| Pravastatin | 16 | $363 | $23 |
| Tamsulosin | 12 | $345 | $29 |
| Lisinopril | 36 | $337 | $9 |
| Amlodipine Besylate | 33 | $306 | $9 |
| Pantoprazole | 12 | $291 | $24 |
| Simvastatin | 18 | $193 | $11 |
| Atenolol | 14 | $164 | $12 |
| Carvedilol | 11 | $151 | $14 |
| Hydrochlorothiazide | 14 | $151 | $11 |
| Metformin | 11 | $92 | $8 |
2019: 33 drugs
| Atorvastatin | 110 | $2,428 | $22 |
| Levothyroxine | 55 | $1,672 | $30 |
| Lisinopril | 76 | $889 | $12 |
| Ventolin Hfa | 13 | $626 | $48 |
| Tamsulosin | 24 | $598 | $25 |
| Losartan | 47 | $570 | $12 |
| Gabapentin | 24 | $564 | $24 |
| Amlodipine Besylate | 53 | $557 | $11 |
| Terazosin | 12 | $535 | $45 |
| Pantoprazole | 24 | $494 | $21 |
| Furosemide | 38 | $467 | $12 |
| Pravastatin | 14 | $463 | $33 |
| Mirtazapine | 16 | $455 | $28 |
| Hydrocodone-Acetaminophen | 35 | $381 | $11 |
| Atenolol | 28 | $321 | $11 |
| Metoprolol | 29 | $308 | $11 |
| Simvastatin | 27 | $307 | $11 |
| Tramadol | 34 | $275 | $8 |
| Morphine Sulfate Er | 15 | $274 | $18 |
| Hydrochlorothiazide | 25 | $266 | $11 |
| Warfarin | 20 | $249 | $12 |
| Lisinopril-Hydrochlorothiazide | 20 | $226 | $11 |
| Alendronate | 21 | $215 | $10 |
| Famotidine | 14 | $190 | $14 |
| Lovastatin | 14 | $179 | $13 |
| Carvedilol | 15 | $170 | $11 |
| Ibuprofen | 12 | $164 | $14 |
| Sumatriptan | 13 | $146 | $11 |
| Metformin | 14 | $139 | $10 |
| Metformin Hcl Er | 13 | $128 | $10 |
| Baclofen | 12 | $128 | $11 |
| Meloxicam | 13 | $80 | $6 |
| Lorazepam | 11 | $66 | $6 |
2018: 28 drugs
| Spiriva Respimat | 13 | $3,772 | $290 |
| Atorvastatin | 42 | $1,187 | $28 |
| Levothyroxine | 25 | $725 | $29 |
| Digoxin | 12 | $712 | $59 |
| Donepezil | 16 | $630 | $39 |
| Hydrocodone-Acetaminophen | 34 | $545 | $16 |
| Lisinopril | 45 | $532 | $12 |
| Baclofen | 21 | $443 | $21 |
| Pantoprazole | 14 | $345 | $25 |
| Furosemide | 25 | $317 | $13 |
| Hydrochlorothiazide | 29 | $302 | $10 |
| Morphine Sulfate Er | 14 | $277 | $20 |
| Amlodipine Besylate | 36 | $276 | $8 |
| Metformin Hcl Er | 16 | $241 | $15 |
| Tamsulosin | 11 | $223 | $20 |
| Simvastatin | 20 | $215 | $11 |
| Losartan | 15 | $208 | $14 |
| Metoprolol | 20 | $186 | $9 |
| Carvedilol | 17 | $170 | $10 |
| Alendronate | 14 | $167 | $12 |
| Atenolol | 21 | $166 | $8 |
| Fluticasone Propionate | 11 | $145 | $13 |
| Lorazepam | 20 | $140 | $7 |
| Lisinopril-Hydrochlorothiazide | 12 | $139 | $12 |
| Tramadol | 15 | $134 | $9 |
| Sertraline | 11 | $127 | $12 |
| Sumatriptan | 11 | $117 | $11 |
| Trazodone | 13 | $111 | $9 |
2017: 6 drugs
| Enalapril Maleate | 22 | $629 | $29 |
| Atorvastatin | 20 | $449 | $22 |
| Levothyroxine | 14 | $119 | $9 |
| Metformin | 14 | $117 | $8 |
| Hydrochlorothiazide | 17 | $64 | $4 |
| Lovastatin | 12 | $49 | $4 |
2016: 3 drugs
| Enalapril Maleate | 12 | $509 | $42 |
| Lovastatin | 11 | $44 | $4 |
| Hydrochlorothiazide | 11 | $22 | $2 |
Money from drug and device companies
$139 in 2025
| 2025 | 3 | 6 | None | $139 |
| 2024 | 3 | 5 | None | $212 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | The Cologuard Plus Collection Kit | $82 | 3 payments
|
| Novo Nordisk | Rybelsus | $33 | 2 payments
|
| Lundbeck | Vyepti | $24 | 1 payment
|
See all 6 published payments
| Exact Sciences | Meals · 2025-10-22 | The Cologuard Plus Collection Kit | $27 |
| Novo Nordisk | Meals · 2025-09-04 | Rybelsus | $17 |
| Novo Nordisk | Meals · 2025-08-28 | None | $16 |
| Exact Sciences | Meals · 2025-08-21 | The Cologuard Plus Collection Kit | $28 |
| Lundbeck | Meals · 2025-04-28 | Vyepti | $24 |
| Exact Sciences | Meals · 2025-03-14 | Cologuard Collection Kit | $27 |
See earlier years (2024)
2024: $212
| GlaxoSmithKline | Arexvy | $122 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $65 | 3 payments
|
| Dynavax Technologies | Heplisav-B | $25 | 1 payment
|
Professional record
- NPI
- 1720406549
- Licence
- CA A145634, IL 125065903California A145634: Current · expires 2027-12-31Illinois 125065903: Expired
- Trained
- Virginia Commonwealth University, School of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 973 University Ave, Los Gatos, CA, 95032
- NPI first listed
- 2014-03-29
- NPI last updated
- 2026-07-21
- NPI record certified
- 2026-07-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2160 S 1st Ave, Maywood, IL, 60153